Bannon J P, Marks G J, Mohiuddin M, Rakinic J, Jian N Z, Nagle D
Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
Ann Surg Oncol. 1995 May;2(3):221-7. doi: 10.1007/BF02307027.
Despite conventional attitudes that interdict sphincter-preservation surgery (SPS) for cancers arising in the terminal 3 cm of rectum, we have selectively employed high-dose preoperative external radiation (HDPER) and either radical or local excisional SPS techniques for rectal cancer arising between the 0.5 and 3 cm levels above the anorectal ring. We have reported a preliminary experience with HDPER and full-thickness local excision (FTLE) and three different methods of radical SPS. We now describe our experience with a single method of radical excision, transanal abdominal transanal proctosigmoidectomy with coloanal anastomosis (TATA) and FTLE in conjunction with HDPER for cancers of the distal 3 cm of rectum based on specific guidelines.
Since 1984, 109 patients with cancers at or below the 3 cm level have been treated with HDPER in doses of 4,500-7,000 cGy and a sphincter-preserving radical or local excision method in a prospective rectal cancer management program. Sixty-five patients (group A) underwent transanal abdominal transanal radical proctosigmoidectomy with colonal anastomosis (TATA) and 44 patients (group B) underwent FTLE.
There was one death (1%). Mean follow-up was 40 months. Local recurrence rates for groups A and B were 9 and 14%, respectively. Kaplan-Meier 5-year actuarial survival was 85 and 90% for groups A and B, respectively, and 87% collectively.
Experience with 109 patients with cancers of the distal 3 cm of rectum indicates that SPS can be accomplished by either radical or local excisional methods with acceptable local control and survival if HDPER and strict selection guidelines are employed.
尽管传统观念禁止对直肠末段3厘米处发生的癌症进行保留括约肌手术(SPS),但我们已选择性地对距肛门直肠环上方0.5至3厘米之间发生的直肠癌采用高剂量术前外照射(HDPER)以及根治性或局部切除性SPS技术。我们已报告了HDPER和全层局部切除(FTLE)以及三种不同根治性SPS方法的初步经验。我们现在根据特定指南描述我们使用单一根治性切除方法——经肛门经腹经肛门直肠乙状结肠切除术并结肠肛管吻合术(TATA)以及FTLE联合HDPER治疗直肠末段3厘米处癌症的经验。
自1984年以来,在一项前瞻性直肠癌管理计划中,109例癌症位于3厘米及以下水平的患者接受了剂量为4500 - 7000 cGy的HDPER以及保留括约肌的根治性或局部切除方法。65例患者(A组)接受了经肛门经腹经肛门根治性直肠乙状结肠切除术并结肠吻合术(TATA),44例患者(B组)接受了FTLE。
有1例死亡(1%)。平均随访时间为40个月。A组和B组的局部复发率分别为9%和14%。A组和B组的Kaplan - Meier 5年精算生存率分别为85%和90%,总体为87%。
109例直肠末段3厘米处癌症患者的经验表明,如果采用HDPER和严格的选择指南,SPS可通过根治性或局部切除方法实现,局部控制和生存率均可接受。